"in conjunction with Coramsine to achieve the spectacular success against mesothelioma in the recent mouse tests"
Mesothelioma was always the original target - a) seemed to work? and b) had fast track advantages as no alternative existed.
Any ideas why this strategy has been ditched - doesn't work as well as expected or is it more effective against the new melanoma target????
cheers, ob2
- Forums
- ASX - By Stock
- SBP
- solbec ann phase 2 targets
SBP
solbec pharmaceuticals limited
solbec ann phase 2 targets, page-3
-
- There are more pages in this discussion • 4 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add SBP (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
SER
STRATEGIC ENERGY RESOURCES LIMITED
David DeTata, Managing Director
David DeTata
Managing Director
SPONSORED BY The Market Online